4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-24-004563
Chief Medical Officer sold 20,563 shares at an average $0.69 ($14,106)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Norry Elliot Chief Medical Officer | 2024-01-16 | Sale | −2,287 | $0.79 | $1,807 | 3,363 | D |
| Norry Elliot Chief Medical Officer | 2024-01-17 | Sale | −5,309 | $0.67 | $3,573 | 7,785 | D |
| Norry Elliot Chief Medical Officer | 2024-01-17 | Sale | −12,967 | $0.67 | $8,727 | 19,257 | D |
| Open-market sales · 20,563 sh · avg $0.69 · $14,106 | |||||||
Loading xslF345X05/tm243270-15_4seq1.xml…